Yi Yu and Elliot Cook of Finnegan, Henderson, Farabow, Garrett & Dunner LLP discuss considerations relating to ...

Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated ...

Avangrid, Inc., a leading energy company and member of the Iberdrola Group, today announced that it has deployed a new solution built to transform field operations, resulting in faster troubleshooting ...

In this series, “Mastery Collides,” co-curated by Hypebeast and Hong Kong Science & Technology Parks Corporation (HKSTP), ...

Q4 2024 Earnings Call Transcript March 27, 2025 IceCure Medical Ltd misses on earnings expectations. Reported EPS is $-0.08 ...

In April 2024, Entera announced that the Journal of Bone and Mineral Research (JBMR) published EB613 placebo controlled Phase ...

We are excited to present four posters with important real-world data from our differentiated pain portfolio at PainConnect 2025 and are grateful to AAPM for selecting our poster at its meeting as a ...

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key ...

AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and ...

GM has filed a patent application for a context-based reminder system for vehicles, potentially providing custom prompts ...

For children with mild sleep disordered breathing (SDB), adenotonsillectomy is associated with reduced all-cause health care utilization.